Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Japan Revenue	705.50B	699.70B	Log In	Log In	Log In	Upgrade
North America Revenue	1.15T	1.10T	Log In	Log In	Log In	Upgrade
Europe Revenue	251.10B	242.90B	Log In	Log In	Log In	Upgrade
Others Revenue	294.40B	292.20B	Log In	Log In	Log In	Upgrade
Overseas Revenue	1.70T	1.63T	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Pharmaceuticals Revenue	1.70T	1.63T	Log In	Log In	Log In	Upgrade
Nutraceuticals Revenue	561.23B	557.01B	Log In	Log In	Log In	Upgrade
Consumer Products Revenue	33.92B	33.75B	Log In	Log In	Log In	Upgrade
Other Segment Revenue	110.46B	110.07B	Log In	Log In	Log In	Upgrade

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Pharmaceuticals Business Profit	417.76B	390.61B	Log In	Log In	Log In	Upgrade
Nutraceuticals Business Profit	62.74B	64.15B	Log In	Log In	Log In	Upgrade
Consumer Products Business Profit	24.28B	23.66B	Log In	Log In	Log In	Upgrade
Other Segment Business Profit	7.33B	6.95B	Log In	Log In	Log In	Upgrade
Eliminations from Business Profit	-56.05B	-54.91B	Log In	Log In	Log In	Upgrade

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Pharmaceuticals Segment Profit	404.44B	285.11B	Log In	Log In	Log In	Upgrade
Nutraceuticals Segment Profit	59.12B	59.78B	Log In	Log In	Log In	Upgrade
Consumer Products Segment Profit	23.57B	23.00B	Log In	Log In	Log In	Upgrade
Other Segment Profit	7.72B	7.53B	Log In	Log In	Log In	Upgrade
Eliminations from Segment Profit	-55.44B	-51.85B	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.